{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-017616","form_type":"8-K","ticker":"VTAK","cik":"0001716621","company_name":"Catheter Precision, Inc.","filed_at":"2025-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.453426+00:00","generated_at":"2026-05-21T01:50:40.767310+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Catheter Precision Q1 revenue up 74% to $143K, net loss $4.0M; cash $450K","bullets":["Revenue $143K vs $82K YoY (+74%); net loss $4.0M including $1.2M non-cash charges.","Cash $450K at March 31; after quarter end secured $1.5M private placement from institutional investors.","Acquired Cardionomics assets via 82%-owned subsidiary Cardionomix, including CPNS system for ADHF.","Acquired PeriKard, LLC (pericardial access kit); first U.S. patent allowed for LockeT device.","Clinical data presented at HRS 2025: VIVO 94% accurate, LockeT safe/effective in 139-patient study."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-017616","json":"https://secwatch.observer/filing/0001437749-25-017616.json","markdown":"https://secwatch.observer/filing/0001437749-25-017616.md","text":"https://secwatch.observer/filing/0001437749-25-017616.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716621/000143774925017616/0001437749-25-017616-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716621/000143774925017616/vtak20250519_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T01:50:40.767310+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}